nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCB1—colon cancer	0.409	1	CbGaD
Spironolactone—ABCC2—Irinotecan—colon cancer	0.0917	0.233	CbGbCtD
Spironolactone—ABCC2—Vincristine—colon cancer	0.0802	0.204	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—colon cancer	0.0586	0.149	CbGbCtD
Spironolactone—ABCC2—Methotrexate—colon cancer	0.0486	0.123	CbGbCtD
Spironolactone—CYP2C8—Fluorouracil—colon cancer	0.0424	0.108	CbGbCtD
Spironolactone—ABCB1—Irinotecan—colon cancer	0.0299	0.076	CbGbCtD
Spironolactone—ABCB1—Vincristine—colon cancer	0.0261	0.0665	CbGbCtD
Spironolactone—ABCB1—Methotrexate—colon cancer	0.0158	0.0402	CbGbCtD
Spironolactone—AR—scrotum—colon cancer	0.0154	0.201	CbGeAlD
Spironolactone—ABCC2—bile—colon cancer	0.00917	0.119	CbGeAlD
Spironolactone—CYP11B2—renal system—colon cancer	0.00346	0.0451	CbGeAlD
Spironolactone—PGR—blood vessel—colon cancer	0.00315	0.041	CbGeAlD
Spironolactone—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00165	0.0375	CcSEcCtD
Spironolactone—CYP11B2—lymph node—colon cancer	0.00162	0.0211	CbGeAlD
Spironolactone—NR3C2—smooth muscle tissue—colon cancer	0.00159	0.0207	CbGeAlD
Spironolactone—PGR—epithelium—colon cancer	0.00153	0.0199	CbGeAlD
Spironolactone—NR3C2—renal system—colon cancer	0.00153	0.0199	CbGeAlD
Spironolactone—PGR—smooth muscle tissue—colon cancer	0.00148	0.0192	CbGeAlD
Spironolactone—SLCO1A2—renal system—colon cancer	0.00131	0.0171	CbGeAlD
Spironolactone—NR3C2—digestive system—colon cancer	0.00125	0.0163	CbGeAlD
Spironolactone—ABCC2—renal system—colon cancer	0.00122	0.0159	CbGeAlD
Spironolactone—AR—epithelium—colon cancer	0.00122	0.0159	CbGeAlD
Spironolactone—SHBG—bone marrow—colon cancer	0.00119	0.0155	CbGeAlD
Spironolactone—PGR—lymphoid tissue—colon cancer	0.00118	0.0154	CbGeAlD
Spironolactone—AR—smooth muscle tissue—colon cancer	0.00118	0.0153	CbGeAlD
Spironolactone—SHBG—vagina—colon cancer	0.00114	0.0149	CbGeAlD
Spironolactone—AR—renal system—colon cancer	0.00113	0.0147	CbGeAlD
Spironolactone—NR3C2—vagina—colon cancer	0.00111	0.0144	CbGeAlD
Spironolactone—NR3C1—embryo—colon cancer	0.00108	0.0141	CbGeAlD
Spironolactone—SLCO1A2—digestive system—colon cancer	0.00108	0.014	CbGeAlD
Spironolactone—Ulcer—Irinotecan—colon cancer	0.00107	0.0243	CcSEcCtD
Spironolactone—PGR—vagina—colon cancer	0.00103	0.0134	CbGeAlD
Spironolactone—Ulcer—Fluorouracil—colon cancer	0.00103	0.0233	CcSEcCtD
Spironolactone—ABCC2—digestive system—colon cancer	0.001	0.013	CbGeAlD
Spironolactone—ABCB1—blood vessel—colon cancer	0.000973	0.0127	CbGeAlD
Spironolactone—SHBG—liver—colon cancer	0.000964	0.0125	CbGeAlD
Spironolactone—AR—lymphoid tissue—colon cancer	0.00094	0.0122	CbGeAlD
Spironolactone—NR3C2—liver—colon cancer	0.000934	0.0122	CbGeAlD
Spironolactone—AR—digestive system—colon cancer	0.000929	0.0121	CbGeAlD
Spironolactone—CYP2C8—renal system—colon cancer	0.000916	0.0119	CbGeAlD
Spironolactone—Rash erythematous—Capecitabine—colon cancer	0.000887	0.0201	CcSEcCtD
Spironolactone—NR3C1—epithelium—colon cancer	0.000884	0.0115	CbGeAlD
Spironolactone—NR3C1—smooth muscle tissue—colon cancer	0.000852	0.0111	CbGeAlD
Spironolactone—AR—vagina—colon cancer	0.00082	0.0107	CbGeAlD
Spironolactone—NR3C1—renal system—colon cancer	0.00082	0.0107	CbGeAlD
Spironolactone—SLCO1A2—liver—colon cancer	0.000801	0.0104	CbGeAlD
Spironolactone—Renal failure acute—Irinotecan—colon cancer	0.000798	0.0181	CcSEcCtD
Spironolactone—ABCC2—liver—colon cancer	0.000746	0.00971	CbGeAlD
Spironolactone—Lethargy—Fluorouracil—colon cancer	0.00072	0.0163	CcSEcCtD
Spironolactone—Ulcer—Capecitabine—colon cancer	0.000718	0.0163	CcSEcCtD
Spironolactone—NR3C2—lymph node—colon cancer	0.000716	0.00932	CbGeAlD
Spironolactone—Ataxia—Vincristine—colon cancer	0.000711	0.0161	CcSEcCtD
Spironolactone—AR—liver—colon cancer	0.000692	0.009	CbGeAlD
Spironolactone—NR3C1—lymphoid tissue—colon cancer	0.000681	0.00886	CbGeAlD
Spironolactone—NR3C1—digestive system—colon cancer	0.000673	0.00875	CbGeAlD
Spironolactone—PGR—lymph node—colon cancer	0.000666	0.00867	CbGeAlD
Spironolactone—Ataxia—Fluorouracil—colon cancer	0.000663	0.015	CcSEcCtD
Spironolactone—Cramp muscle—Irinotecan—colon cancer	0.000663	0.015	CcSEcCtD
Spironolactone—CYP2C8—vagina—colon cancer	0.000663	0.00863	CbGeAlD
Spironolactone—NR3C1—bone marrow—colon cancer	0.00062	0.00807	CbGeAlD
Spironolactone—Eosinophilia—Fluorouracil—colon cancer	0.000604	0.0137	CcSEcCtD
Spironolactone—Erectile dysfunction—Vincristine—colon cancer	0.000602	0.0137	CcSEcCtD
Spironolactone—NR3C1—vagina—colon cancer	0.000594	0.00773	CbGeAlD
Spironolactone—ABCB1—embryo—colon cancer	0.00058	0.00755	CbGeAlD
Spironolactone—ABCC2—lymph node—colon cancer	0.000572	0.00744	CbGeAlD
Spironolactone—CYP2C8—liver—colon cancer	0.00056	0.00728	CbGeAlD
Spironolactone—Renal failure—Irinotecan—colon cancer	0.000558	0.0127	CcSEcCtD
Spironolactone—Ulcer—Methotrexate—colon cancer	0.000535	0.0121	CcSEcCtD
Spironolactone—Renal failure acute—Capecitabine—colon cancer	0.000534	0.0121	CcSEcCtD
Spironolactone—AR—lymph node—colon cancer	0.000531	0.0069	CbGeAlD
Spironolactone—Vasculitis—Methotrexate—colon cancer	0.000518	0.0117	CcSEcCtD
Spironolactone—Agranulocytosis—Fluorouracil—colon cancer	0.000507	0.0115	CcSEcCtD
Spironolactone—Lethargy—Capecitabine—colon cancer	0.000503	0.0114	CcSEcCtD
Spironolactone—NR3C1—liver—colon cancer	0.000501	0.00652	CbGeAlD
Spironolactone—ABCB1—epithelium—colon cancer	0.000473	0.00616	CbGeAlD
Spironolactone—Ataxia—Capecitabine—colon cancer	0.000464	0.0105	CcSEcCtD
Spironolactone—Alopecia—Vincristine—colon cancer	0.000462	0.0105	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—colon cancer	0.000452	0.0103	CcSEcCtD
Spironolactone—Alopecia—Irinotecan—colon cancer	0.00045	0.0102	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000444	0.0101	CcSEcCtD
Spironolactone—ABCB1—renal system—colon cancer	0.000439	0.00571	CbGeAlD
Spironolactone—Gastritis—Capecitabine—colon cancer	0.000436	0.00989	CcSEcCtD
Spironolactone—Alopecia—Fluorouracil—colon cancer	0.000431	0.00978	CcSEcCtD
Spironolactone—Muscle spasms—Irinotecan—colon cancer	0.000427	0.00967	CcSEcCtD
Spironolactone—Ill-defined disorder—Irinotecan—colon cancer	0.000412	0.00933	CcSEcCtD
Spironolactone—Leukopenia—Vincristine—colon cancer	0.000408	0.00924	CcSEcCtD
Spironolactone—Malaise—Irinotecan—colon cancer	0.0004	0.00907	CcSEcCtD
Spironolactone—Renal failure acute—Methotrexate—colon cancer	0.000398	0.00901	CcSEcCtD
Spironolactone—Leukopenia—Irinotecan—colon cancer	0.000397	0.009	CcSEcCtD
Spironolactone—NR3C1—lymph node—colon cancer	0.000384	0.005	CbGeAlD
Spironolactone—Leukopenia—Fluorouracil—colon cancer	0.00038	0.00862	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000377	0.00854	CcSEcCtD
Spironolactone—Drospirenone—PTGS2—colon cancer	0.000375	0.332	CrCbGaD
Spironolactone—Lethargy—Methotrexate—colon cancer	0.000375	0.00849	CcSEcCtD
Spironolactone—Renal failure—Capecitabine—colon cancer	0.000374	0.00847	CcSEcCtD
Spironolactone—Discomfort—Irinotecan—colon cancer	0.000373	0.00846	CcSEcCtD
Spironolactone—Anaphylactic shock—Vincristine—colon cancer	0.000372	0.00843	CcSEcCtD
Spironolactone—Megestrol acetate—ABCB1—colon cancer	0.000365	0.323	CrCbGaD
Spironolactone—Confusional state—Irinotecan—colon cancer	0.000365	0.00828	CcSEcCtD
Spironolactone—ABCB1—lymphoid tissue—colon cancer	0.000365	0.00474	CbGeAlD
Spironolactone—Thrombocytopenia—Vincristine—colon cancer	0.000364	0.00825	CcSEcCtD
Spironolactone—Anaphylactic shock—Irinotecan—colon cancer	0.000362	0.00821	CcSEcCtD
Spironolactone—ABCB1—digestive system—colon cancer	0.00036	0.00469	CbGeAlD
Spironolactone—Discomfort—Fluorouracil—colon cancer	0.000357	0.0081	CcSEcCtD
Spironolactone—Agranulocytosis—Capecitabine—colon cancer	0.000355	0.00804	CcSEcCtD
Spironolactone—Thrombocytopenia—Irinotecan—colon cancer	0.000355	0.00804	CcSEcCtD
Spironolactone—Confusional state—Fluorouracil—colon cancer	0.00035	0.00793	CcSEcCtD
Spironolactone—Anaphylactic shock—Fluorouracil—colon cancer	0.000347	0.00786	CcSEcCtD
Spironolactone—Ataxia—Methotrexate—colon cancer	0.000345	0.00782	CcSEcCtD
Spironolactone—Thrombocytopenia—Fluorouracil—colon cancer	0.00034	0.0077	CcSEcCtD
Spironolactone—ABCB1—bone marrow—colon cancer	0.000332	0.00432	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000331	0.00749	CcSEcCtD
Spironolactone—Erythema multiforme—Capecitabine—colon cancer	0.000323	0.00731	CcSEcCtD
Spironolactone—Somnolence—Irinotecan—colon cancer	0.000322	0.0073	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Vincristine—colon cancer	0.000321	0.00728	CcSEcCtD
Spironolactone—ABCB1—vagina—colon cancer	0.000318	0.00414	CbGeAlD
Spironolactone—Eosinophilia—Methotrexate—colon cancer	0.000314	0.00712	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000313	0.00709	CcSEcCtD
Spironolactone—Somnolence—Fluorouracil—colon cancer	0.000308	0.00699	CcSEcCtD
Spironolactone—Alopecia—Capecitabine—colon cancer	0.000301	0.00683	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000299	0.00679	CcSEcCtD
Spironolactone—Feeling abnormal—Irinotecan—colon cancer	0.000298	0.00676	CcSEcCtD
Spironolactone—Body temperature increased—Vincristine—colon cancer	0.000294	0.00666	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—colon cancer	0.000292	0.00662	CcSEcCtD
Spironolactone—Body temperature increased—Irinotecan—colon cancer	0.000286	0.00649	CcSEcCtD
Spironolactone—Feeling abnormal—Fluorouracil—colon cancer	0.000286	0.00648	CcSEcCtD
Spironolactone—Muscle spasms—Capecitabine—colon cancer	0.000285	0.00647	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—colon cancer	0.000283	0.00641	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00028	0.00636	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—colon cancer	0.000278	0.0063	CcSEcCtD
Spironolactone—Ill-defined disorder—Capecitabine—colon cancer	0.000276	0.00625	CcSEcCtD
Spironolactone—Urticaria—Fluorouracil—colon cancer	0.000276	0.00625	CcSEcCtD
Spironolactone—Body temperature increased—Fluorouracil—colon cancer	0.000274	0.00622	CcSEcCtD
Spironolactone—Hypersensitivity—Vincristine—colon cancer	0.000274	0.00621	CcSEcCtD
Spironolactone—ABCB1—liver—colon cancer	0.000268	0.00349	CbGeAlD
Spironolactone—Malaise—Capecitabine—colon cancer	0.000268	0.00607	CcSEcCtD
Spironolactone—Hypersensitivity—Irinotecan—colon cancer	0.000267	0.00605	CcSEcCtD
Spironolactone—Leukopenia—Capecitabine—colon cancer	0.000266	0.00603	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—colon cancer	0.000264	0.00598	CcSEcCtD
Spironolactone—Hypersensitivity—Fluorouracil—colon cancer	0.000256	0.00579	CcSEcCtD
Spironolactone—Diarrhoea—Vincristine—colon cancer	0.000254	0.00577	CcSEcCtD
Spironolactone—Discomfort—Capecitabine—colon cancer	0.00025	0.00566	CcSEcCtD
Spironolactone—Diarrhoea—Irinotecan—colon cancer	0.000248	0.00562	CcSEcCtD
Spironolactone—Dizziness—Vincristine—colon cancer	0.000246	0.00557	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—EP300—colon cancer	0.000246	0.00324	CbGpPWpGaD
Spironolactone—Pruritus—Fluorouracil—colon cancer	0.000245	0.00556	CcSEcCtD
Spironolactone—Confusional state—Capecitabine—colon cancer	0.000244	0.00554	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CASP3—colon cancer	0.000243	0.00321	CbGpPWpGaD
Spironolactone—Erythema multiforme—Methotrexate—colon cancer	0.00024	0.00544	CcSEcCtD
Spironolactone—Dizziness—Irinotecan—colon cancer	0.000239	0.00543	CcSEcCtD
Spironolactone—Diarrhoea—Fluorouracil—colon cancer	0.000237	0.00538	CcSEcCtD
Spironolactone—Thrombocytopenia—Capecitabine—colon cancer	0.000237	0.00538	CcSEcCtD
Spironolactone—Vomiting—Vincristine—colon cancer	0.000236	0.00536	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—HRAS—colon cancer	0.000235	0.00309	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CTNNB1—colon cancer	0.000235	0.00309	CbGpPWpGaD
Spironolactone—Rash—Vincristine—colon cancer	0.000234	0.00531	CcSEcCtD
Spironolactone—Dermatitis—Vincristine—colon cancer	0.000234	0.00531	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—colon cancer	0.000234	0.00309	CbGpPWpGaD
Spironolactone—Headache—Vincristine—colon cancer	0.000233	0.00528	CcSEcCtD
Spironolactone—Vomiting—Irinotecan—colon cancer	0.00023	0.00522	CcSEcCtD
Spironolactone—Dizziness—Fluorouracil—colon cancer	0.000229	0.0052	CcSEcCtD
Spironolactone—Rash—Irinotecan—colon cancer	0.000228	0.00518	CcSEcCtD
Spironolactone—Dermatitis—Irinotecan—colon cancer	0.000228	0.00517	CcSEcCtD
Spironolactone—Headache—Irinotecan—colon cancer	0.000227	0.00514	CcSEcCtD
Spironolactone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.000226	0.00298	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000225	0.00297	CbGpPWpGaD
Spironolactone—Alopecia—Methotrexate—colon cancer	0.000224	0.00509	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—EP300—colon cancer	0.000223	0.00294	CbGpPWpGaD
Spironolactone—Nausea—Vincristine—colon cancer	0.000221	0.00501	CcSEcCtD
Spironolactone—Vomiting—Fluorouracil—colon cancer	0.000221	0.005	CcSEcCtD
Spironolactone—NR3C1—Endoderm Differentiation—APC—colon cancer	0.00022	0.0029	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.00022	0.0029	CbGpPWpGaD
Spironolactone—Rash—Fluorouracil—colon cancer	0.000219	0.00496	CcSEcCtD
Spironolactone—Dermatitis—Fluorouracil—colon cancer	0.000218	0.00495	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—CHST5—colon cancer	0.000218	0.00288	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ODC1—colon cancer	0.000218	0.00288	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—FGFR3—colon cancer	0.000218	0.00287	CbGpPWpGaD
Spironolactone—Headache—Fluorouracil—colon cancer	0.000217	0.00493	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—SRC—colon cancer	0.000217	0.00286	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CCND1—colon cancer	0.000217	0.00286	CbGpPWpGaD
Spironolactone—Nausea—Irinotecan—colon cancer	0.000215	0.00488	CcSEcCtD
Spironolactone—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.000215	0.00283	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000209	0.00474	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.000207	0.00273	CbGpPWpGaD
Spironolactone—Nausea—Fluorouracil—colon cancer	0.000206	0.00467	CcSEcCtD
Spironolactone—ABCB1—lymph node—colon cancer	0.000206	0.00268	CbGeAlD
Spironolactone—Ill-defined disorder—Methotrexate—colon cancer	0.000205	0.00465	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000201	0.00265	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.0002	0.00264	CbGpPWpGaD
Spironolactone—Feeling abnormal—Capecitabine—colon cancer	0.0002	0.00453	CcSEcCtD
Spironolactone—Malaise—Methotrexate—colon cancer	0.000199	0.00452	CcSEcCtD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000198	0.00262	CbGpPWpGaD
Spironolactone—Leukopenia—Methotrexate—colon cancer	0.000198	0.00449	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—CA7—colon cancer	0.000194	0.00257	CbGpPWpGaD
Spironolactone—Urticaria—Capecitabine—colon cancer	0.000193	0.00436	CcSEcCtD
Spironolactone—Body temperature increased—Capecitabine—colon cancer	0.000192	0.00434	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—TGFB1—colon cancer	0.00019	0.0025	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ODC1—colon cancer	0.000188	0.00248	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CHST5—colon cancer	0.000188	0.00248	CbGpPWpGaD
Spironolactone—Discomfort—Methotrexate—colon cancer	0.000186	0.00422	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—HNF4A—colon cancer	0.000184	0.00242	CbGpPWpGaD
Spironolactone—Confusional state—Methotrexate—colon cancer	0.000182	0.00412	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—colon cancer	0.00018	0.00409	CcSEcCtD
Spironolactone—Hypersensitivity—Capecitabine—colon cancer	0.000179	0.00405	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—colon cancer	0.000177	0.004	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000176	0.00232	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.000174	0.0023	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.000173	0.00228	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000173	0.00228	CbGpPWpGaD
Spironolactone—Pruritus—Capecitabine—colon cancer	0.000171	0.00389	CcSEcCtD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	0.000169	0.00223	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000167	0.0022	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000166	0.00219	CbGpPWpGaD
Spironolactone—Diarrhoea—Capecitabine—colon cancer	0.000166	0.00376	CcSEcCtD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	0.000165	0.00217	CbGpPWpGaD
Spironolactone—NR3C1—Circadian Clock—EP300—colon cancer	0.000164	0.00217	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.000161	0.00212	CbGpPWpGaD
Spironolactone—Somnolence—Methotrexate—colon cancer	0.00016	0.00364	CcSEcCtD
Spironolactone—Dizziness—Capecitabine—colon cancer	0.00016	0.00363	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.00016	0.00211	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000159	0.0021	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.000159	0.00209	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000156	0.00353	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.000155	0.00204	CbGpPWpGaD
Spironolactone—Vomiting—Capecitabine—colon cancer	0.000154	0.00349	CcSEcCtD
Spironolactone—Rash—Capecitabine—colon cancer	0.000153	0.00346	CcSEcCtD
Spironolactone—Dermatitis—Capecitabine—colon cancer	0.000153	0.00346	CcSEcCtD
Spironolactone—Headache—Capecitabine—colon cancer	0.000152	0.00344	CcSEcCtD
Spironolactone—Hydrocortisone—ABCB1—colon cancer	0.000151	0.133	CrCbGaD
Spironolactone—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	0.000149	0.00197	CbGpPWpGaD
Spironolactone—Feeling abnormal—Methotrexate—colon cancer	0.000149	0.00337	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.000147	0.00194	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	0.000147	0.00194	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000146	0.00192	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—HNF4A—colon cancer	0.000145	0.00192	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—DLC1—colon cancer	0.000144	0.00191	CbGpPWpGaD
Spironolactone—Nausea—Capecitabine—colon cancer	0.000144	0.00326	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000144	0.0019	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.000143	0.00189	CbGpPWpGaD
Spironolactone—Urticaria—Methotrexate—colon cancer	0.000143	0.00325	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—colon cancer	0.000143	0.00323	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000141	0.00186	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—HNF4A—colon cancer	0.00014	0.00185	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.00014	0.00185	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000139	0.00183	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000136	0.0018	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LGR5—colon cancer	0.000136	0.00179	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—EP300—colon cancer	0.000136	0.00179	CbGpPWpGaD
Spironolactone—Hypersensitivity—Methotrexate—colon cancer	0.000133	0.00301	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—CDKN1A—colon cancer	0.000133	0.00175	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—AKT1—colon cancer	0.000132	0.00174	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	0.000132	0.00174	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—PPARG—colon cancer	0.000131	0.00173	CbGpPWpGaD
Spironolactone—Pruritus—Methotrexate—colon cancer	0.000128	0.00289	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000127	0.00167	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000127	0.00167	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—PPARG—colon cancer	0.000126	0.00167	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.000126	0.00166	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	0.000126	0.00166	CbGpPWpGaD
Spironolactone—Diarrhoea—Methotrexate—colon cancer	0.000123	0.0028	CcSEcCtD
Spironolactone—Progesterone—ABCB1—colon cancer	0.000123	0.109	CrCbGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000121	0.00159	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	0.000121	0.00159	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	0.000121	0.00159	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	0.000119	0.00158	CbGpPWpGaD
Spironolactone—Dizziness—Methotrexate—colon cancer	0.000119	0.0027	CcSEcCtD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000119	0.00157	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MYC—colon cancer	0.000118	0.00156	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—NRAS—colon cancer	0.000118	0.00156	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	0.000118	0.00155	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ODC1—colon cancer	0.000118	0.00155	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CHST5—colon cancer	0.000118	0.00155	CbGpPWpGaD
Spironolactone—Testosterone—ABCB1—colon cancer	0.000116	0.103	CrCbGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000115	0.00151	CbGpPWpGaD
Spironolactone—Vomiting—Methotrexate—colon cancer	0.000115	0.0026	CcSEcCtD
Spironolactone—Rash—Methotrexate—colon cancer	0.000114	0.00258	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—colon cancer	0.000114	0.00258	CcSEcCtD
Spironolactone—Headache—Methotrexate—colon cancer	0.000113	0.00256	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000108	0.00142	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—EGFR—colon cancer	0.000107	0.00142	CbGpPWpGaD
Spironolactone—Nausea—Methotrexate—colon cancer	0.000107	0.00243	CcSEcCtD
Spironolactone—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	0.000106	0.0014	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000105	0.00139	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000105	0.00139	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000105	0.00138	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000104	0.00137	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—KRAS—colon cancer	0.000102	0.00134	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000101	0.00134	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AXIN2—colon cancer	9.76e-05	0.00129	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—colon cancer	9.7e-05	0.00128	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	9.66e-05	0.00127	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	9.62e-05	0.00127	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	9.61e-05	0.00127	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA7—colon cancer	9.56e-05	0.00126	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—EP300—colon cancer	9.41e-05	0.00124	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—PIK3CA—colon cancer	9.33e-05	0.00123	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	9.18e-05	0.00121	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	9.15e-05	0.00121	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9e-05	0.00119	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	8.93e-05	0.00118	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	8.91e-05	0.00118	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—AKT1—colon cancer	8.91e-05	0.00118	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—CTNNB1—colon cancer	8.89e-05	0.00117	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—HNF4A—colon cancer	8.85e-05	0.00117	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	8.7e-05	0.00115	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—CDKN1A—colon cancer	8.68e-05	0.00115	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—colon cancer	8.63e-05	0.00114	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	8.61e-05	0.00114	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	8.55e-05	0.00113	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	8.44e-05	0.00111	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	8.42e-05	0.00111	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	8.41e-05	0.00111	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA7—colon cancer	8.33e-05	0.0011	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	8.23e-05	0.00109	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	8e-05	0.00106	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—PPARG—colon cancer	7.98e-05	0.00105	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	7.97e-05	0.00105	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	7.78e-05	0.00103	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	7.78e-05	0.00103	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.76e-05	0.00102	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	7.68e-05	0.00101	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	7.63e-05	0.00101	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—AKT1—colon cancer	7.62e-05	0.00101	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	7.58e-05	0.001	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFB1—colon cancer	7.48e-05	0.000986	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—colon cancer	7.47e-05	0.000985	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CASP3—colon cancer	7.38e-05	0.000973	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	7.29e-05	0.000961	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	7.23e-05	0.000954	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	7.22e-05	0.000952	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TGFB1—colon cancer	7.18e-05	0.000947	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	7.14e-05	0.000942	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.08e-05	0.000934	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	7.04e-05	0.000928	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	6.98e-05	0.00092	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	6.96e-05	0.000918	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	6.91e-05	0.000912	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	6.82e-05	0.0009	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	6.78e-05	0.000894	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	6.76e-05	0.000892	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HNF4A—colon cancer	6.74e-05	0.000889	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	6.65e-05	0.000877	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	6.45e-05	0.00085	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PPARG—colon cancer	6.31e-05	0.000832	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—colon cancer	6.26e-05	0.000826	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.1e-05	0.000805	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PPARG—colon cancer	6.08e-05	0.000802	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	6.05e-05	0.000798	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5.92e-05	0.000781	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.89e-05	0.000777	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	5.84e-05	0.00077	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CHST5—colon cancer	5.79e-05	0.000764	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ODC1—colon cancer	5.79e-05	0.000764	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ABCB1—colon cancer	5.76e-05	0.00076	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TGFB1—colon cancer	5.75e-05	0.000758	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	5.73e-05	0.000756	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TYMS—colon cancer	5.66e-05	0.000746	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	5.17e-05	0.000681	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HNF4A—colon cancer	5.11e-05	0.000674	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.08e-05	0.000669	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CHST5—colon cancer	5.04e-05	0.000665	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ODC1—colon cancer	5.04e-05	0.000665	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ABCB1—colon cancer	4.97e-05	0.000655	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TYMS—colon cancer	4.88e-05	0.000643	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.86e-05	0.000642	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.84e-05	0.000638	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.61e-05	0.000608	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	4.61e-05	0.000608	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—colon cancer	4.55e-05	0.0006	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.36e-05	0.000575	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—colon cancer	4.01e-05	0.000529	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	3.92e-05	0.000517	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—colon cancer	3.84e-05	0.000507	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.83e-05	0.000505	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.75e-05	0.000495	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	3.64e-05	0.00048	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—colon cancer	3.6e-05	0.000474	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	3.54e-05	0.000467	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	3.51e-05	0.000463	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—colon cancer	3.46e-05	0.000457	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—colon cancer	3.45e-05	0.000456	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.43e-05	0.000452	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.26e-05	0.00043	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.18e-05	0.00042	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	3.17e-05	0.000418	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—colon cancer	3.15e-05	0.000416	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—colon cancer	3.11e-05	0.000411	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	3.09e-05	0.000408	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—colon cancer	3.06e-05	0.000403	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—colon cancer	2.93e-05	0.000386	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.84e-05	0.000375	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.84e-05	0.000374	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGFR3—colon cancer	2.82e-05	0.000372	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.78e-05	0.000367	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—colon cancer	2.72e-05	0.000358	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	2.63e-05	0.000347	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.63e-05	0.000346	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—EP300—colon cancer	2.62e-05	0.000346	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—colon cancer	2.59e-05	0.000341	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—colon cancer	2.49e-05	0.000329	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—colon cancer	2.43e-05	0.000321	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.41e-05	0.000318	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.39e-05	0.000315	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.35e-05	0.00031	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.33e-05	0.000308	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—EP300—colon cancer	2.26e-05	0.000298	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—colon cancer	2.22e-05	0.000293	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—colon cancer	2.19e-05	0.000289	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—colon cancer	2.17e-05	0.000286	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.97e-05	0.00026	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—colon cancer	1.94e-05	0.000256	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.88e-05	0.000248	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—colon cancer	1.82e-05	0.000241	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—colon cancer	1.77e-05	0.000234	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—colon cancer	1.76e-05	0.000232	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—colon cancer	1.72e-05	0.000226	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—colon cancer	1.7e-05	0.000225	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—colon cancer	1.67e-05	0.000221	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—colon cancer	1.67e-05	0.00022	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EP300—colon cancer	1.63e-05	0.000215	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—colon cancer	1.59e-05	0.00021	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—colon cancer	1.59e-05	0.000209	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.56e-05	0.000206	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—colon cancer	1.55e-05	0.000204	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—colon cancer	1.53e-05	0.000202	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—colon cancer	1.53e-05	0.000202	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—colon cancer	1.52e-05	0.0002	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—colon cancer	1.5e-05	0.000198	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—colon cancer	1.42e-05	0.000188	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—colon cancer	1.42e-05	0.000187	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—EP300—colon cancer	1.42e-05	0.000187	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—colon cancer	1.39e-05	0.000184	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—colon cancer	1.37e-05	0.00018	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—colon cancer	1.32e-05	0.000174	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—colon cancer	1.31e-05	0.000173	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—colon cancer	1.27e-05	0.000167	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—colon cancer	1.21e-05	0.000159	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—colon cancer	1.17e-05	0.000154	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—colon cancer	1.16e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.16e-05	0.000153	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—colon cancer	1.12e-05	0.000147	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—colon cancer	1.06e-05	0.00014	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—colon cancer	1.05e-05	0.000138	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—colon cancer	9.87e-06	0.00013	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—colon cancer	9.27e-06	0.000122	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—colon cancer	8.78e-06	0.000116	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—colon cancer	8.56e-06	0.000113	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—colon cancer	8.37e-06	0.00011	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—colon cancer	7.29e-06	9.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—EP300—colon cancer	6.96e-06	9.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—EP300—colon cancer	6.07e-06	8e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—colon cancer	5.15e-06	6.79e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—colon cancer	4.49e-06	5.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—colon cancer	4.21e-06	5.55e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—colon cancer	3.67e-06	4.84e-05	CbGpPWpGaD
